Cited by 609Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Tau and tauopathies

Arendt, Thomas, Stieler, Jens T., Holzer, Max·2016·Brain Research Bulletin

Abstract

Most neurodegenerative diseases are characterized by intracellular aggregates of insoluble proteins. As for the majority of these disorders, aetiology and pathogenesis are only poorly understood; current nosological concepts are largely based on these molecular signatures of protein aggregates which also provide valuable tools for neuropathological differential diagnosis. The microtubule associated protein tau is one of these proteins that form intracellular fibrillary deposits in neurons and glial cells of a large variety of disorders today collectively referred to as tauopathies. While dysfunction of tau has unequivocally been shown to be able to cause neurodegeneration, the precise mechanisms of how tau is involved in neurodegenerative disorders is still poorly understood. After research has focused for several decades on the axonal function of tau and on the fibrillar tau aggregation, more recent cell biological studies have opened up new insights into the role of tau at the synapse and in the nucleus. According to currently emerging cell biological concepts, tau might play a role in the regulation of neuronal plasticity in a wide array of neuronal networks. In addition, it might be involved in regulating genome stability. The most intriguing question relevant both to physiological and pathophysiological function of tau is the biological meaning of the large heterogeneity of isoforms of tau which apparently is a rather promiscuous molecule. The present review is divided into two parts. First, we give an overview on the molecular biology and cell biology of tau and its physiological functions. The second part deals with the pathophysiology of tau and description of tauopathies which comprise more than 20 disorders including Alzheimer's disease, progressive supranuclear palsy, cortico basal degeneration, Pick's disease and others.

Integrity signals

Registry

Crossref · 10.1016/j.brainresbull.2016.08.018

Cites

1115 of 1115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several tauopathies including PSP, CBD, FTDP-17, and AGD exclusively feature 4R tau deposits.

    “Aggregates composed of both 3R and 4R tau are seen in disease states, though curiously several tauopathies including PSP, CBD, FTDP-17, and AGD exclusively feature 4R tau deposits.”

    From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [2]

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arendt, T., Stieler, J. T., & Holzer, M.
Affiliations
Leipzig University (DE)
Corresponding author
Arendt, Thomas
Venue
Brain Research Bulletin
Publisher
Elsevier BV
Published
2016-09
Volume
126
Issue
Pt 3
Pages
238-292
ISSN
0361-9230 (ISSN-L)
OpenAlex
W2519516239
Cited by
609
References
1,115
Citations by year
2026: 34 · 2025: 62 · 2024: 75 · 2023: 65 · 2022: 80 · 2021: 74 · 2020: 74 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 1
FWCI
5.63
Type
journal article
Language
en
Open access
closed
Locations
  • Brain Research Bulletin (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • DFG (AR 200/17-1, HO2368-4/1)
  • Era Net Rus Plus (DLR/01DJ16018)
  • Fritz Thyssen Foundation
  • EU funds (100111005)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
tau protein, tauopathy, neurodegeneration, protein aggregation, synapses, neuroplasticity, genome stability, tau isoforms, Alzheimer's disease, progressive supranuclear palsy, corticobasal degeneration, Pick's disease
MeSH terms
Animals, Humans, tau Proteins, Tauopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review